REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 63 filers reported holding REPARE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,660,268 | +13.9% | 2,620,883 | -0.3% | 0.24% | +31.5% |
| Q2 2023 | $27,805,012 | +3.2% | 2,628,073 | -4.0% | 0.18% | -0.5% |
| Q1 2023 | $26,935,268 | -24.6% | 2,737,324 | +12.7% | 0.18% | -40.3% |
| Q4 2022 | $35,716,689 | +11.9% | 2,428,055 | -7.7% | 0.31% | +39.0% |
| Q3 2022 | $31,926,000 | +25.1% | 2,632,028 | -5.3% | 0.22% | +47.7% |
| Q2 2022 | $25,514,000 | -37.7% | 2,779,331 | -3.3% | 0.15% | -11.7% |
| Q1 2022 | $40,944,000 | -34.9% | 2,875,315 | -3.5% | 0.17% | -10.0% |
| Q4 2021 | $62,866,000 | -19.2% | 2,980,836 | +0.5% | 0.19% | +1.6% |
| Q3 2021 | $77,847,000 | +23.2% | 2,966,739 | +46.3% | 0.19% | +58.5% |
| Q2 2021 | $63,207,000 | +51.6% | 2,027,160 | +49.2% | 0.12% | +42.2% |
| Q1 2021 | $41,695,000 | +91.3% | 1,358,589 | +113.8% | 0.08% | +43.1% |
| Q4 2020 | $21,794,000 | – | 635,393 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $32,989,176 | 13.80% |
| CHI Advisors LLC | 2,800,126 | $41,189,854 | 10.97% |
| MPM BioImpact LLC | 1,639,849 | $24,122,179 | 6.26% |
| BVF INC/IL | 8,291,988 | $121,975,143 | 5.15% |
| Deep Track Capital, LP | 2,727,606 | $40,123,084 | 1.68% |
| Redmile Group, LLC | 2,684,396 | $39,487,465 | 1.62% |
| HighVista Strategies LLC | 164,890 | $2,425,532 | 1.44% |
| Orbimed Advisors | 3,322,488 | $48,873,798 | 0.94% |
| Artal Group S.A. | 700,000 | $10,297 | 0.58% |
| HARBOR CAPITAL ADVISORS, INC. | 34,572 | $508,554 | 0.49% |